RecallDepth
Class II Ongoing

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .

This recall is currently active, issued May 28, 2025. It was issued by Asttrazeneca Pharmaceuticals Lp.

Company
Asttrazeneca Pharmaceuticals Lp
Recall Initiated
May 14, 2025
Posted
May 28, 2025
Recall Number
D-0444-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 807,837 canisters; b) 235,698 canisters
Firm Location
Wilmington, DE, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective delivery system

Distribution

USA Nationwide

Lot / Code Info

Lot#: a) 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027; b) Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026

Other recent Class II Drug recalls